Inventor · disambiguated record
Jeffrey L. Cleland
Also filed as: CLELAND JEFFREY · CLELAND JEFFREY L · HSU CHUNG C
50 granted patents·39 pending applications·3,525 citations·filing 1994–2024
99Inventor score
Files withGENENTECH INC22GRAYBUG VISION INC21ASHVATTHA THERAPEUTICS INC11AMUNIX OPERATING INC8NOVACEA INC6
Top patents by PatentIndex Score
89 records- 0198US8673860B2Extended recombinant polypeptides and compositions comprising sameSCHELLENBERGER VOLKER·Filed 2010·Granted Mar 18, 2014·99 cites·20 claims
- 0298US7682609B2Protein formulationGENENTECH INC·Filed 2006·Granted Mar 23, 2010·77 cites·30 claims
- 0398US7060268B2Protein formulationGENENTECH INC·Filed 2003·Granted Jun 13, 2006·208 cites·3 claims
- 0498US6821515B1Protein formulationGENENTECH INC·Filed 2000·Granted Nov 23, 2004·209 cites·23 claims
- 0598US6685940B2Protein formulationGENENTECH INC·Filed 2001·Granted Feb 3, 2004·402 cites·15 claims
- 0698US6267958B1Protein formulationGENENTECH INC·Filed 1996·Granted Jul 31, 2001·1.5k cites·47 claims
- 0796US10961287B2Extended recombinant polypeptides and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2018·Granted Mar 30, 2021·10 cites·19 claims
- 0896US9926351B2Extended recombinant polypeptides and compositions comprising sameAMUNIX OPERATING INC·Filed 2016·Granted Mar 27, 2018·19 cites·37 claims
- 0996US9371369B2Extended recombinant polypeptides and compositions comprising sameAMUNIX OPERATING INC·Filed 2014·Granted Jun 21, 2016·30 cites·37 claims
- 1096US8703717B2Growth hormone polypeptides and methods of making and using sameSCHELLENBERGER VOLKER·Filed 2010·Granted Apr 22, 2014·41 cites·84 claims
- 1196US8680050B2Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using sameSCHELLENBERGER VOLKER·Filed 2010·Granted Mar 25, 2014·31 cites·26 claims
- 1296US7651703B2Injection vehicle for polymer-based formulationsGENENTECH INC·Filed 2006·Granted Jan 26, 2010·41 cites·22 claims
- 1396US5589167AExcipient stabilization of polypeptides treated with organic solventsGENENTECH INC·Filed 1994·Granted Dec 31, 1996·191 cites·16 claims
- 1495US9849188B2Growth hormone polypeptides and methods of making and using sameAMUNIX OPERATING INC·Filed 2015·Granted Dec 26, 2017·10 cites·24 claims
- 1595US9283273B2Protein formulationANDYA JAMES·Filed 2012·Granted Mar 15, 2016·20 cites·16 claims
- 1695US7318931B2Sustained release formulationGENENTECH INC·Filed 2002·Granted Jan 15, 2008·66 cites·29 claims
- 1794US10000543B2Glucose-regulating polypeptides and methods of making and using sameAMUNIX OPERATING INC·Filed 2016·Granted Jun 19, 2018·13 cites·17 claims
- 1894US9168312B2Growth hormone polypeptides and methods of making and using sameAMUNIX OPERATING INC·Filed 2014·Granted Oct 27, 2015·23 cites·20 claims
- 1993US8957021B2Glucose-regulating polypeptides and methods of making and using sameSCHELLENBERGER VOLKER·Filed 2010·Granted Feb 17, 2015·19 cites·30 claims
- 2092US9540430B2Glucose-regulating polypeptides and methods of making and using sameAMUNIX OPERATING INC·Filed 2014·Granted Jan 10, 2017·15 cites·20 claims
- 2192US8501216B2Bioerodible polymers for injectionCLELAND JEFFREY L·Filed 2010·Granted Aug 6, 2013·11 cites·48 claims
- 2292US7582311B1Injection vehicle for polymer-based formulationsGENENTECH INC·Filed 2000·Granted Sep 1, 2009·52 cites·44 claims
- 2389US6113947AControlled release microencapsulated NGF formulationGENENTECH INC·Filed 1997·Granted Sep 5, 2000·94 cites·31 claims
- 2489US2025051405A1Extended recombinant polypeptides and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2588US7824700B2Erodible polymers for injectionGENENTECH INC·Filed 2002·Granted Nov 2, 2010·19 cites·54 claims
- 2688US5643605AMethods and compositions for microencapsulation of adjuvantsGENENTECH INC·Filed 1995·Granted Jul 1, 1997·101 cites·9 claims
- 2787US9808531B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2016·Granted Nov 7, 2017·5 cites·27 claims
- 2886US8067020B2Sustained release formulationOKUMU FRANKLIN·Filed 2007·Granted Nov 29, 2011·6 cites·11 claims
- 2985US11612660B2Dendrimer compositions and methods for drug delivery to the eyeASHVATTHA THERAPEUTICS INC·Filed 2020·Granted Mar 28, 2023·2 cites·19 claims
- 3085US8906648B2Recombinant production of vascular endothelial growth factorGENENTECH INC·Filed 2013·Granted Dec 9, 2014·6 cites·16 claims
- 3183US2025242037A1Dendrimer compositions and methods for drug delivery to the eyeASHVATTHA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3282US12121585B2Dendrimer compositions and methods for drug delivery to the eyeASHVATTHA THERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·0 cites·20 claims
- 3381US9956302B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted May 1, 2018·2 cites·50 claims
- 3481US8273561B2High pressure treatment of aggregated interferonsCLELAND JEFFREY L·Filed 2008·Granted Sep 25, 2012·4 cites·7 claims
- 3581US5804557AExcipient stabilization of polypeptides treated with organic solventsGENENTECH INC·Filed 1996·Granted Sep 8, 1998·44 cites·8 claims
- 3680US6913767B1Compositions for microencapsulation of antigens for use as vaccinesGENENTECH INC·Filed 1997·Granted Jul 5, 2005·60 cites·13 claims
- 3779US11160870B2Extended release microparticles and suspensions thereof for medical therapyGRAYBUG VISION INC·Filed 2018·Granted Nov 2, 2021·1 cites·57 claims
- 3878US10159747B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted Dec 25, 2018·1 cites·49 claims
- 3978US10117950B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted Nov 6, 2018·1 cites·48 claims
- 4078US10111964B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted Oct 30, 2018·1 cites·37 claims
- 4178US10098965B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted Oct 16, 2018·1 cites·47 claims
- 4278US7163701B2Controlled release microencapsulated NGF formulationGENENTECH INC·Filed 2003·Granted Jan 16, 2007·7 cites·11 claims
- 4377US2024041783A1Aggregating microparticles for medical therapyGRAYBUG VISION INC·Filed 2023·Application pending·0 cites
- 4476US12071456B2Extended recombinant polypeptides and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2021·Granted Aug 27, 2024·0 cites·7 claims
- 4576US11331276B2Aggregating microparticles for medical therapyGRAYBUG VISION INC·Filed 2019·Granted May 17, 2022·1 cites·35 claims
- 4675US6080429AMethod for drying microspheresGENENTECH INC·Filed 1997·Granted Jun 27, 2000·45 cites·24 claims
- 4774US11564890B2Aggregating microparticles for medical therapyGRAYBUG VISION INC·Filed 2019·Granted Jan 31, 2023·0 cites·59 claims
- 4873US10441548B2Aggregating microparticles for medical therapyGRAYBUG VISION INC·Filed 2016·Granted Oct 15, 2019·1 cites·78 claims
- 4972US2025009894A1Dendrimer compositions and methods for treatment of severe acute respiratory distress syndromeASHVATTHA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 5070US2023372499A1Dendrimer compositions and methods for drug deliveryUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
Showing the top 50 of 89 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →